N. Galiè, M. Humbert, and J. Vachiery, 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the, ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)

M. Humbert, O. Sitbon, and A. Chaouat, Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9
DOI : 10.1164/rccm.200510-1668OC

J. Newman, L. Wheeler, and K. Lane, Mutation in the Gene for Bone Morphogenetic Protein Receptor II as a Cause of Primary Pulmonary Hypertension in a Large Kindred, New England Journal of Medicine, vol.345, issue.5, pp.319-343, 2001.
DOI : 10.1056/NEJM200108023450502

R. Trembath, J. Thomson, and R. Machado, Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia, New England Journal of Medicine, vol.345, issue.5, pp.325-359, 2001.
DOI : 10.1056/NEJM200108023450503

L. Ma, D. Roman-campos, and E. Austin, A Novel Channelopathy in Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.369, issue.4, pp.351-61, 2013.
DOI : 10.1056/NEJMoa1211097

E. Austin, L. Ma, and C. Leduc, Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension, Circulation: Cardiovascular Genetics, vol.5, issue.3, pp.336-379, 2012.
DOI : 10.1161/CIRCGENETICS.111.961888

B. Sztrymf, F. Coulet, and B. Girerd, Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation

B. Girerd, D. Montani, and F. Coulet, ) Mutation, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.8, pp.851-61, 2010.
DOI : 10.1164/rccm.200908-1284OC

J. Evans, B. Girerd, and D. Montani, BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis, The Lancet Respiratory Medicine, vol.4, issue.2, pp.129-166, 2014.
DOI : 10.1016/S2213-2600(15)00544-5

URL : http://doi.org/10.1016/s2213-2600(15)00544-5

J. Tenorio, P. Navas, and E. Barrios, mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies, Clinical Genetics, vol.270, issue.6, pp.579-83, 2015.
DOI : 10.1111/cge.12549

D. Best, K. Sumner, and E. Austin, EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis, Chest, vol.145, issue.2, pp.231-267, 2014.
DOI : 10.1378/chest.13-2366

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921094

D. Montani, E. Lau, and P. Dorfmüller, Pulmonary veno-occlusive disease, European Respiratory Journal, vol.47, issue.5, pp.1518-1552, 2016.
DOI : 10.1183/13993003.00026-2016

URL : https://hal.archives-ouvertes.fr/inserm-01436297

D. Montani, A. Descatha, and E. Lau, Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease, European Respiratory Journal, vol.46, issue.6, pp.1721-1752, 2015.
DOI : 10.1183/13993003.00814-2015

B. Ranchoux, S. Günther, and R. Quarck, Chemotherapy-induced pulmonary hypertension: Role of alkylating agents, European Respiratory Journal, vol.46, issue.suppl 59, pp.356-71, 2015.
DOI : 10.1183/13993003.congress-2015.PA581

F. Perros, S. Günther, and B. Ranchoux, Mitomycin-Induced Pulmonary Veno-Occlusive DiseaseCLINICAL PERSPECTIVE, Circulation, vol.132, issue.9, pp.834-881, 2015.
DOI : 10.1161/CIRCULATIONAHA.115.014207

D. Montani, L. Achouh, and P. Dorfmüller, Pulmonary Veno-Occlusive Disease, Medicine, vol.87, issue.4, pp.220-253, 2008.
DOI : 10.1097/MD.0b013e31818193bb

URL : https://hal.archives-ouvertes.fr/inserm-01436297

J. Mandel, E. Mark, and C. Hales, Pulmonary Veno-occlusive Disease, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.5, pp.1964-73, 2000.
DOI : 10.1164/ajrccm.162.5.9912045

S. Palmer, L. Robinson, A. Wang, J. Gossage, T. Bashore et al., Massive Pulmonary Edema and Death After Prostacyclin Infusion in a Patient With Pulmonary Veno-occlusive Disease, Chest, vol.113, issue.1, pp.237-277, 1998.
DOI : 10.1378/chest.113.1.237

G. Simonneau, M. Gatzoulis, and I. Adatia, Updated Clinical Classification of Pulmonary Hypertension, Journal of the American College of Cardiology, vol.62, issue.25, pp.34-41, 2013.
DOI : 10.1016/j.jacc.2013.10.029

M. Humbert, O. Sitbon, and G. Simonneau, Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1461, 2004.
DOI : 10.1056/NEJMra040291

URL : https://hal.archives-ouvertes.fr/hal-01455600

M. Humbert, E. Lau, D. Montani, X. Jaïs, O. Sitbon et al., Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension, Circulation, vol.130, issue.24, pp.2189-208, 2014.
DOI : 10.1161/CIRCULATIONAHA.114.006974

P. Enright and D. Sherrill, Reference Equations for the Six-Minute Walk in Healthy Adults, American Journal of Respiratory and Critical Care Medicine, vol.158, issue.5, pp.1384-87, 1998.
DOI : 10.1164/ajrccm.158.5.9710086

J. Fine and R. Gray, A Proportional Hazards Model for the Subdistribution of a Competing Risk, Journal of the American Statistical Association, vol.69, issue.446, pp.496-509, 1999.
DOI : 10.2307/2530374

M. Noordzij, K. Leff-ondré, K. Van-stralen, C. Zoccali, F. Dekker et al., When do we need competing risks methods for survival analysis in nephrology?, Nephrology Dialysis Transplantation, vol.28, issue.11, pp.2670-77, 2013.
DOI : 10.1093/ndt/gft355

P. Andersen, R. Geskus, T. De-witte, and H. Putter, Competing risks in epidemiology: possibilities and pitfalls, International Journal of Epidemiology, vol.41, issue.3, pp.861-70, 2012.
DOI : 10.1093/ije/dyr213

B. Lau, S. Cole, and S. Gange, Competing Risk Regression Models for Epidemiologic Data, American Journal of Epidemiology, vol.170, issue.2, pp.244-56, 2009.
DOI : 10.1093/aje/kwp107

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732996

A. 29-resten, S. Maitre, and M. Humbert, CT of the Chest in Pulmonary Venoocclusive Disease, American Journal of Roentgenology, vol.183, issue.1, pp.65-70, 2004.
DOI : 10.2214/ajr.183.1.1830065

P. Trip, B. Girerd, and H. Bogaard, Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension, European Respiratory Journal, vol.43, issue.4, pp.1195-98, 2014.
DOI : 10.1183/09031936.00136413

B. Girerd, D. Montani, and X. Jaïs, Genetic counselling in a national referral centre for pulmonary hypertension, European Respiratory Journal, vol.47, issue.2, pp.541-52, 2015.
DOI : 10.1183/13993003.00717-2015

A. Ogawa, K. Miyaji, and I. Yamadori, Safety and Efficacy of Epoprostenol Therapy in Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis, Circulation Journal, vol.76, issue.7, pp.1729-1765, 2012.
DOI : 10.1253/circj.CJ-11-0973

K. Wille, N. Sharma, and T. Kulkarni, Characteristics of Patients with Pulmonary Venoocclusive Disease Awaiting Transplantation, Annals of the American Thoracic Society, vol.11, issue.9, pp.1411-1429, 2014.
DOI : 10.1513/AnnalsATS.201408-354OC

M. Levy, M. Eyries, and I. Szezepanski, Genetic analyses in a cohort of children with pulmonary hypertension, European Respiratory Journal, vol.48, issue.4, pp.1118-1144, 2016.
DOI : 10.1183/13993003.00211-2016